CN101274029A - Compound formulation of capsules for curing hemorrhoidal bleeding and preparing process - Google Patents

Compound formulation of capsules for curing hemorrhoidal bleeding and preparing process Download PDF

Info

Publication number
CN101274029A
CN101274029A CNA2007100541318A CN200710054131A CN101274029A CN 101274029 A CN101274029 A CN 101274029A CN A2007100541318 A CNA2007100541318 A CN A2007100541318A CN 200710054131 A CN200710054131 A CN 200710054131A CN 101274029 A CN101274029 A CN 101274029A
Authority
CN
China
Prior art keywords
anal fistula
compound formulation
capsule
percent
rhizoma coptidis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007100541318A
Other languages
Chinese (zh)
Inventor
王忠东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LUOYANG ZISHENG TECHNOLOGY DEVELOPMENT Co Ltd
Original Assignee
LUOYANG ZISHENG TECHNOLOGY DEVELOPMENT Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LUOYANG ZISHENG TECHNOLOGY DEVELOPMENT Co Ltd filed Critical LUOYANG ZISHENG TECHNOLOGY DEVELOPMENT Co Ltd
Priority to CNA2007100541318A priority Critical patent/CN101274029A/en
Publication of CN101274029A publication Critical patent/CN101274029A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a composition method and a preparation technique of a capsule for treating anal fistula, which are characterized in that: raw materials of 0.5 to 1.5 percent of coptis, 0.5 to 1.5 percent of fuligo herbis and 0.5 to 1.5 percent of dark plum meat are mixed, dried, ground and encapsulated, and then irradiated and inspected so as to obtain finished products which are put in storage. The capsule can treat symptoms of weakness, frequent vertigo and anal fistula and the symptoms can be recuperated to normal state by persisting in taking the capsule and one can feel that all parts of body recover to normal state. Besides, pure traditional Chinese medicine causes no dependence to human body and the price is low, thereby being especially applicable to mass consumption and operation by manufacturers.

Description

Capsular compound formulation of a kind of treatment anal fistula and processing technology
Affiliated technical field:
The present invention relates to the processing technology of compound formulation of capsules, especially a kind of compound formulation and processing technology for the treatment of anal fistula.
Background technology:
At present, along with growth in the living standard, people more pay attention to drinking and eating from the diet aspect, healthy green health and tonic, health care has also entered the common people's life thereupon, and is as physical weakness, often dizzy, anal fistula occurs and allow the people neglect especially, go out China's application (patent) number by retrieval: 02139328.1 applying date: 2002.08.03 open (bulletin) number: CN1401382 open (bulletin) day: 2003.03.12
Application (patent) number: 01133502.5 applying date: 2001.09.26 open (bulletin) number: CN1410081 open (bulletin) day: 2003.04.16
Summary of the invention:
The present invention is in order to solve physical weakness, and is often dizzy, and a difficult problem that hernia occurs provides a kind of assembly than (weight) and processing technology: Rhizoma Coptidis 0.5-1.5%, and Pulvis Fumi Carbonisatus 0.5-1.5% Fructus Mume 0.5-1.5%.Get above raw material mixing and dry, pulverize, incapsulate, be the finished product warehouse-in after irradiation, the check.
Best group proportioning (weight) is: Rhizoma Coptidis 1%, Pulvis Fumi Carbonisatus 1% Fructus Mume 1% is got above raw material mixing and is dried, pulverizes, incapsulates, and is the finished product warehouse-in after irradiation, the check.
Beneficial effect:
The invention has the beneficial effects as follows: can effectively be physical weakness, often dizzy, the symptom that anal fistula occurs obtains medical treatment, taking for a long time can be with physical weakness, and often dizzy, the symptom that anal fistula occurs is nursed one's health to normal condition, can feel that parts of body returns back to normal condition, and pure Chinese medicine product is to the human body no dependence, and price is the end again, is particularly suitable for the operation of mass consumption and manufacturer.
Description of drawings:
The present invention is further described below in conjunction with accompanying drawing:
Fig. 1 is a process chart of the present invention.
Embodiment one:
Rhizoma Coptidis 0.5-1.5%, Pulvis Fumi Carbonisatus 0.5-1.5% Fructus Mume 0.5-1.5%.Get above raw material mixing and dry, pulverize, incapsulate, be the finished product warehouse-in after irradiation, the check.
Embodiment two:
Rhizoma Coptidis 1.5%, Pulvis Fumi Carbonisatus 1.5% Fructus Mume 1.5%
Embodiment three:
Rhizoma Coptidis 0.5%, Pulvis Fumi Carbonisatus 0.5% Fructus Mume 0.5%.
The specific embodiment:
Rhizoma Coptidis 1%, Pulvis Fumi Carbonisatus 1% Fructus Mume 1% is got above raw material mixing and is dried, pulverizes, incapsulates, and is the finished product warehouse-in after irradiation, the check.

Claims (3)

1. treat capsular compound formulation of anal fistula and processing technology for one kind, it is characterized in that: Rhizoma Coptidis 0.5-1.5%, Pulvis Fumi Carbonisatus 0.5-1.5% Fructus Mume 0.5-1.5% gets above raw material mixing and dries, pulverizes, incapsulates, and is the finished product warehouse-in after irradiation, the check.
2. according to capsular compound formulation of a kind of treatment anal fistula and the processing technology described in the claim 1, it is characterized in that: Rhizoma Coptidis 1%, Pulvis Fumi Carbonisatus 1% Fructus Mume 1%.
3. according to capsular compound formulation of a kind of treatment anal fistula and the processing technology described in the claim 1, it is characterized in that: Rhizoma Coptidis 0.5%, Pulvis Fumi Carbonisatus 0.5% Fructus Mume 0.5% is got above raw material mixing and is dried, pulverizes, incapsulates, and is the finished product warehouse-in after irradiation, the check.
CNA2007100541318A 2007-03-27 2007-03-27 Compound formulation of capsules for curing hemorrhoidal bleeding and preparing process Pending CN101274029A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007100541318A CN101274029A (en) 2007-03-27 2007-03-27 Compound formulation of capsules for curing hemorrhoidal bleeding and preparing process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007100541318A CN101274029A (en) 2007-03-27 2007-03-27 Compound formulation of capsules for curing hemorrhoidal bleeding and preparing process

Publications (1)

Publication Number Publication Date
CN101274029A true CN101274029A (en) 2008-10-01

Family

ID=39994163

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007100541318A Pending CN101274029A (en) 2007-03-27 2007-03-27 Compound formulation of capsules for curing hemorrhoidal bleeding and preparing process

Country Status (1)

Country Link
CN (1) CN101274029A (en)

Similar Documents

Publication Publication Date Title
CN102138605A (en) Tea capable of nourishing stomach and tonifying spleen
CN105288215A (en) High-activity dendrobium officinale kimura et migo freeze-drying powder buccal tablets and preparation process thereof
CN102138607A (en) Tea capable of tonifying middle-Jiao and Qi
CN101274009A (en) Compound formulation of capsule for treating lumbocrural pain and its preparing process
CN101810716A (en) Preparation method of Chinese pulsatilla root submicron powder at normal temperature
CN103504134A (en) Meat duck feed additive
CN110419718A (en) The functional food and preparation method thereof of Chinese herbal treatment diabetes
CN101274051A (en) Compound formulation of capsules for treating barrenness and preparation process thereof
CN103284162A (en) Aloe vera gel functional food
CN106417817A (en) Tea bag with effects of helping sleep and soothing nerves and preparation method thereof
CN101972390A (en) Traditional Chinese medicine composite for preventing and treating foot-and-mouth disease and preparation method thereof
CN101274029A (en) Compound formulation of capsules for curing hemorrhoidal bleeding and preparing process
CN103263538B (en) Traditional Chinese medicine combination with nourishing, anti-inflammation, antidiarrheal, hemostatic and analgesic effects for livestock and preparation method thereof
CN101274048A (en) Compound formulation of capsules for curing injuries from falls and preparing technique
CN101879238A (en) Medicinal composition for preventing and controlling chicken colibacillosis and preparation method thereof
CN101274069A (en) Compound formulation of capsules for curing nephritis and preparing technique
CN101274010A (en) Compound formulation of capsules for curing female frigidity and preparing technique
CN106138215A (en) A kind of medicine for treating eczema
CN104906362B (en) A kind of Chinese medicine preparation for treating Shelled Turtle Trionyx Sinensis enteritis and preparation method thereof
CN101274030A (en) Compound formulation of capsules for invigorating yang and preparing technique
CN102406740B (en) Pure Chinese traditional medicine composition for treating poultry tissues trichomoniasis and its preparation method
CN101274083A (en) Compound formulation of capsules for curing dysmenorrheal, non-stopping menstruation and preparing technique
KR101485261B1 (en) Composition for rolling pills comprising adlay and rolling method thereof
CN101274091A (en) Compound formulation of capsules for curing cold and preparing technique
CN101274068A (en) Compound formulation of alcohol-relieving capsule and its preparing process

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20081001